Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Cleton-Jansen

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Virchows Archiv : an International Journal of Pathology|October 12, 2014
Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasisM Lieveld, E Bodson, G De Boeck, et al.
British Journal of Cancer|February 24, 2006
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell linesM Lombaerts, T van Wezel, K Philippo, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
Oncogenesis|May 10, 2016
Targeting survivin as a potential new treatment for chondrosarcoma of boneY de Jong, J G van Oosterwijk, A B Kruisselbrink, et al.
British Journal of Cancer|September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryJ Posthumadeboer, S R Piersma, T V Pham, et al.
Genomics|February 26, 1999
The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancerJ Crawford, L Ianzano, M Savino, et al.
Cancer Research|February 28, 2001
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regionsA M Cleton-Jansen, D F Callen, R Seshadri, et al.
Genomics|May 1, 1997
The genomic organization of the Fanconi anemia group A (FAA) geneL Ianzano, M D'Apolito, M Centra, et al.
Head and Neck Pathology|May 8, 2025
Recurrent MDM2 Amplification in the Spectrum of HMGA2-Altered Pleomorphic Adenoma, Atypical Pleomorphic Adenoma and Carcinoma Ex Pleomorphic AdenomaKimberly S T Burghout, G E Breimer, S Koppes, et al.
Genomics|June 20, 1998
Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancerS A Whitmore, J Crawford, S Apostolou, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Virchows Archiv : an International Journal of Pathology|October 12, 2014
Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasisM Lieveld, E Bodson, G De Boeck, et al.
British Journal of Cancer|February 24, 2006
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell linesM Lombaerts, T van Wezel, K Philippo, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
Oncogenesis|May 10, 2016
Targeting survivin as a potential new treatment for chondrosarcoma of boneY de Jong, J G van Oosterwijk, A B Kruisselbrink, et al.
British Journal of Cancer|September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryJ Posthumadeboer, S R Piersma, T V Pham, et al.
Genomics|February 26, 1999
The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancerJ Crawford, L Ianzano, M Savino, et al.
Cancer Research|February 28, 2001
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regionsA M Cleton-Jansen, D F Callen, R Seshadri, et al.
Genomics|May 1, 1997
The genomic organization of the Fanconi anemia group A (FAA) geneL Ianzano, M D'Apolito, M Centra, et al.
Head and Neck Pathology|May 8, 2025
Recurrent MDM2 Amplification in the Spectrum of HMGA2-Altered Pleomorphic Adenoma, Atypical Pleomorphic Adenoma and Carcinoma Ex Pleomorphic AdenomaKimberly S T Burghout, G E Breimer, S Koppes, et al.
Genomics|June 20, 1998
Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancerS A Whitmore, J Crawford, S Apostolou, et al.
Pageof 7